Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > β-(N-Methylamino)-L-alanine

β-(N-Methylamino)-L-alanine

β-(N-Methylamino)-L-alanine structure

β-(N-Methylamino)-L-alanine 

structure
  • CAS No:

    15920-93-1

  • Formula:

    C4H10N2O2

  • Chemical Name:

    β-(N-Methylamino)-L-alanine

  • Synonyms:

    L-Alanine,3-(methylamino)-;Propionic acid,2-amino-3-(methylamino)-,L-;3-(Methylamino)-L-alanine;L-α-Amino-β-(methylamino)propionic acid;β-(N-Methylamino)-L-alanine;L-(β-Methylamino)alanine;S(+)-β-Methyl-α,β-diaminopropionic acid;BMMA;β-Methylamino-L-alanine

  • Categories:

    Biochemical Engineering  >  Amino Acids and Derivatives

Description

ChEBI: A non-proteinogenic L-alpha-amino acid that is L-alanine in which one of the methyl hydrogens is replaced by a methylamino group. A non-proteinogenic amino acid produced by cyanobacteria, it is a neurotoxi that has been postulated as a possible cause of neurodegenerative disorders of aging such as Alzheimer's disease, amyotrophic lateral sclerosis, and the amyotrophic lateral sclerosis/parkinsonism-dementia complex (ALS-PDC) syndrome of Guam.


L-BMAA is a non-proteinogenic L-alpha-amino acid that is L-alanine in which one of the methyl hydrogens is replaced by a methylamino group. A non-proteinogenic amino acid produced by cyanobacteria, it is a neurotoxin that has been postulated as a possible cause of neurodegenerative disorders of aging such as Alzheimer's disease, amyotrophic lateral sclerosis, and the amyotrophic lateral sclerosis/parkinsonism-dementia complex (ALS-PDC) syndrome of Guam. It has a role as a neurotoxin and a bacterial metabolite. It is a secondary amino compound, a non-proteinogenic L-alpha-amino acid, a L-alanine derivative and a diamino acid.

β-(N-Methylamino)-L-alanine Basic Attributes

118.13

118.13

108SA6URTV

DTXSID60166611

Characteristics

75.4

-4.00 (est)

white solid

1.157 g/cm3

284.2ºC at 760 mmHg

125.7ºC

1.484

solutions may be stored for several days at 4#x00b0;Csoluble

−20°C

3.9X10-9 mm Hg at 25 deg C (est)

other linear non-peptide (BMAA)

Safety Information

IRRITANT

3

22-24/25

Drug Information

Drugs that bind to and activate excitatory amino acid receptors. (See all compounds classified as Excitatory Amino Acid Agonists.)

2-amino-3(methylamino)propionic acid

β-(N-Methylamino)-L-alanine Use and Manufacturing

Neurotoxic glutamate agonist originally isolated from Cycas circinalis. Implicated in the pathogenesis of amyotrophic lateral sclerosis-Parkinsonism-dementia complex of Guam (Guam ALS-PD).

Computed Properties

Molecular Weight:118.13
XLogP3:-3.8
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:3
Exact Mass:118.074227566
Monoisotopic Mass:118.074227566
Topological Polar Surface Area:75.4
Heavy Atom Count:8
Complexity:84.1
Defined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of β-(N-Methylamino)-L-alanine

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.